lextemy
mylan ire healthcare limited - bevatsizumab - colorectal neoplasms; breast neoplasms; ovarian neoplasms; fallopian tube neoplasms; peritoneal neoplasms; carcinoma, non-small-cell lung; carcinoma, renal cell; uterine cervical neoplasms - antineoplastilised ained - treatment of carcinoma of the colon or rectum, breast cancer, non-small cell lung cancer, renal cell cancer, epithelial ovarian, fallopian tube or primary peritoneal cancer, and carcinoma of the cervix.
legacy® 500 sc
adama - suspensioonikontsentraat - diflufenikaan - herbitsiidid
tomahawk® 200 ec
adama - emulsioonikontsentraat - fluroksüpüür - herbitsiidid
bioparox nina-/suuõõnesprei, lahus
les laboratoires servier - fusafungiin - nina-/suuõõnesprei, lahus - 0,125mg 1annus 10ml 1tk
bioparox nina-/suuõõnesprei, lahus
first pharma oÜ - fusafungiin - nina-/suuõõnesprei, lahus - 0,125mg 1annus 10ml 1tk
trimmer® 50 sg
adama - vees dispergeeruvad graanulid - tribenuroon-metüül - herbitsiidid